- Megavog MF 0.3/500 mg Tablet effectively lowers blood sugar levels in patients with type 2 diabetes.
- This formulation helps improve glycemic control, reducing the risk of diabetes-related complications.
- Weight management is supported by the dual action of Metformin and Voglibose in Megavog MF 0.3/500 mg Tablet.
- Patients using Megavog MF 0.3/500 mg Tablet may experience improved insulin sensitivity.
- The medication is beneficial for those who have not achieved adequate control with diet and exercise alone.
- Megavog MF 0.3/500 mg Tablet can be used as part of a comprehensive diabetes management plan.
- This therapy may help reduce postprandial (after meal) blood glucose spikes.
- Megavog MF 0.3/500 mg Tablet is suitable for patients who are overweight or obese and require blood sugar control.
- The combination therapy in Megavog MF 0.3/500 mg Tablet allows for lower doses of each component, minimizing side effects.
- Regular use of Megavog MF 0.3/500 mg Tablet can lead to long-term health benefits for diabetic patients.
Megavog MF 0.3/500 mg Tablet - Strip of 10
Compositions : Voglibose 0.3mg + Metformin Hydrochloride 500mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Aristo Pharmaceuticals Pvt Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Megavog MF 0.3/500 mg Tablet is a pharmaceutical formulation designed to assist in the management of diabetes mellitus, particularly in patients with type 2 diabetes. This medication combines two active ingredients: Metformin and Voglibose, which work synergistically to help control blood sugar levels effectively. The key composition of Megavog MF 0.3/500 mg Tablet includes 0.3 mg of Voglibose and 500 mg of Metformin, making it a potent option for those requiring glucose regulation. As a member of the therapeutic category known as antidiabetics, Megavog MF 0.3/500 mg Tablet plays a crucial role in improving glycemic control in individuals with insulin resistance or inadequate insulin secretion. The primary purpose of Megavog MF 0.3/500 mg Tablet is to lower blood glucose levels, thereby reducing the risk of complications associated with uncontrolled diabetes. By utilizing the dual action of its components, this medication not only helps in managing blood sugar levels but also aids in weight management, making it an ideal choice for overweight diabetic patients. The formulation is designed to be taken orally, providing convenience and ease of use for patients. With its effective combination, Megavog MF 0.3/500 mg Tablet is an essential part of a comprehensive diabetes management plan, which may also include dietary modifications and physical activity. Regular monitoring of blood glucose levels is recommended while using Megavog MF 0.3/500 mg Tablet to ensure optimal therapeutic outcomes and adjust dosages as necessary. Overall, Megavog MF 0.3/500 mg Tablet represents a significant advancement in diabetes care, offering patients a reliable option for maintaining their health and well-being.
Product Details
- Megavog MF 0.3/500 mg Tablet works through a dual mechanism to control blood sugar levels effectively. The combination of Metformin and Voglibose provides comprehensive management for type 2 diabetes.
- Metformin: Reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues.
- Voglibose: Slows down carbohydrate absorption from the intestines, leading to reduced postprandial glucose levels.
- The synergistic effect of both components in Megavog MF 0.3/500 mg Tablet helps maintain stable blood sugar levels throughout the day.
- This combination also aids in weight management, which is crucial for many diabetic patients.
- By improving insulin action and reducing glucose absorption, Megavog MF 0.3/500 mg Tablet helps prevent complications associated with diabetes.
- The recommended dosage for adults using Megavog MF 0.3/500 mg Tablet is typically one tablet taken orally with meals.
- Dosage may be adjusted based on individual blood glucose levels and physician recommendations.
- It is advisable to take Megavog MF 0.3/500 mg Tablet at the same time each day to maintain consistent blood sugar control.
- The frequency of administration is usually two to three times daily, depending on the prescribed regimen.
- Patients should not exceed the recommended dosage without consulting their healthcare provider.
- Duration of treatment with Megavog MF 0.3/500 mg Tablet should be determined by a healthcare professional based on individual needs.
- Special instructions include monitoring blood glucose levels regularly while on this medication.
- Patients should inform their doctor about any other medications they are taking to avoid potential interactions.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Megavog MF 0.3/500 mg Tablet.
- Regular physical activity can enhance the effectiveness of this medication; aim for at least 150 minutes of moderate exercise weekly.
- Avoid excessive consumption of sugary foods and beverages to help manage blood sugar levels effectively.
- Stay hydrated by drinking plenty of water throughout the day while on Megavog MF 0.3/500 mg Tablet.
- Monitor blood glucose levels regularly to assess the effectiveness of the treatment plan.
Safety Advice
Side Effects
- Common side effects associated with Megavog MF 0.3/500 mg Tablet include gastrointestinal disturbances such as nausea, vomiting, and diarrhea.
- Some patients may experience abdominal discomfort or bloating while taking this medication.
- Serious side effects can include lactic acidosis, especially in patients with renal impairment.
- Signs of lactic acidosis include unusual muscle pain, difficulty breathing, and feeling cold or dizzy; immediate medical attention is required if these occur.
- Allergic reactions are rare but can happen; symptoms may include rash, itching, or swelling.
- Patients should report any persistent side effects to their healthcare provider for further evaluation.
Precautions and Warnings
- Megavog MF 0.3/500 mg Tablet should not be used by individuals with known hypersensitivity to Metformin or Voglibose.
- This medication is contraindicated in patients with severe renal impairment or acute metabolic acidosis.
- Pregnant or breastfeeding women should consult their healthcare provider before using Megavog MF 0.3/500 mg Tablet.
- Caution is advised when driving or operating machinery until individual responses to the medication are known.
- Alcohol consumption should be limited while taking Megavog MF 0.3/500 mg Tablet due to the risk of lactic acidosis.
- Patients with liver disease should use this medication under strict medical supervision.
- Regular monitoring of kidney function is recommended during treatment with Megavog MF 0.3/500 mg Tablet.
FAQs
Megavog MF 0.3/500 mg Tablet is primarily used for managing blood sugar levels in individuals with type 2 diabetes.
2. How should I take Megavog MF 0.3/500 mg Tablet?
It is recommended to take Megavog MF 0.3/500 mg Tablet orally with meals as prescribed by your healthcare provider.
3. What are the common side effects?
Common side effects may include gastrointestinal issues such as nausea, vomiting, and diarrhea.
4. Can I drink alcohol while taking this medication?
It is advisable to limit alcohol intake while using Megavog MF 0.3/500 mg Tablet due to potential risks.
5. Who should avoid using Megavog MF 0.3/500 mg Tablet?
Individuals with severe renal impairment or hypersensitivity to its components should avoid using this medication.
6. How does this medication work?
Megavog MF 0.3/500 mg Tablet works by combining Metformin and Voglibose to lower blood sugar levels effectively.
7. What should I do if I miss a dose?
If you miss a dose of Megavog MF 0.3/500 mg Tablet, take it as soon as you remember unless it's almost time for your next dose.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 102063 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Aristo Pharmaceuticals Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Megavog MF 0.3/500 mg Tablet is a pharmaceutical formulation designed to assist in the management of diabetes mellitus, particularly in patients with type 2 diabetes. This medication combines two active ingredients: Metformin and Voglibose, which work synergistically to help control blood sugar levels effectively. The key composition of Megavog MF 0.3/500 mg Tablet includes 0.3 mg of Voglibose and 500 mg of Metformin, making it a potent option for those requiring glucose regulation. As a member of the therapeutic category known as antidiabetics, Megavog MF 0.3/500 mg Tablet plays a crucial role in improving glycemic control in individuals with insulin resistance or inadequate insulin secretion. The primary purpose of Megavog MF 0.3/500 mg Tablet is to lower blood glucose levels, thereby reducing the risk of complications associated with uncontrolled diabetes. By utilizing the dual action of its components, this medication not only helps in managing blood sugar levels but also aids in weight management, making it an ideal choice for overweight diabetic patients. The formulation is designed to be taken orally, providing convenience and ease of use for patients. With its effective combination, Megavog MF 0.3/500 mg Tablet is an essential part of a comprehensive diabetes management plan, which may also include dietary modifications and physical activity. Regular monitoring of blood glucose levels is recommended while using Megavog MF 0.3/500 mg Tablet to ensure optimal therapeutic outcomes and adjust dosages as necessary. Overall, Megavog MF 0.3/500 mg Tablet represents a significant advancement in diabetes care, offering patients a reliable option for maintaining their health and well-being.
- Megavog MF 0.3/500 mg Tablet effectively lowers blood sugar levels in patients with type 2 diabetes.
- This formulation helps improve glycemic control, reducing the risk of diabetes-related complications.
- Weight management is supported by the dual action of Metformin and Voglibose in Megavog MF 0.3/500 mg Tablet.
- Patients using Megavog MF 0.3/500 mg Tablet may experience improved insulin sensitivity.
- The medication is beneficial for those who have not achieved adequate control with diet and exercise alone.
- Megavog MF 0.3/500 mg Tablet can be used as part of a comprehensive diabetes management plan.
- This therapy may help reduce postprandial (after meal) blood glucose spikes.
- Megavog MF 0.3/500 mg Tablet is suitable for patients who are overweight or obese and require blood sugar control.
- The combination therapy in Megavog MF 0.3/500 mg Tablet allows for lower doses of each component, minimizing side effects.
- Regular use of Megavog MF 0.3/500 mg Tablet can lead to long-term health benefits for diabetic patients.
- Megavog MF 0.3/500 mg Tablet works through a dual mechanism to control blood sugar levels effectively. The combination of Metformin and Voglibose provides comprehensive management for type 2 diabetes.
- Metformin: Reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues.
- Voglibose: Slows down carbohydrate absorption from the intestines, leading to reduced postprandial glucose levels.
- The synergistic effect of both components in Megavog MF 0.3/500 mg Tablet helps maintain stable blood sugar levels throughout the day.
- This combination also aids in weight management, which is crucial for many diabetic patients.
- By improving insulin action and reducing glucose absorption, Megavog MF 0.3/500 mg Tablet helps prevent complications associated with diabetes.
- The recommended dosage for adults using Megavog MF 0.3/500 mg Tablet is typically one tablet taken orally with meals.
- Dosage may be adjusted based on individual blood glucose levels and physician recommendations.
- It is advisable to take Megavog MF 0.3/500 mg Tablet at the same time each day to maintain consistent blood sugar control.
- The frequency of administration is usually two to three times daily, depending on the prescribed regimen.
- Patients should not exceed the recommended dosage without consulting their healthcare provider.
- Duration of treatment with Megavog MF 0.3/500 mg Tablet should be determined by a healthcare professional based on individual needs.
- Special instructions include monitoring blood glucose levels regularly while on this medication.
- Patients should inform their doctor about any other medications they are taking to avoid potential interactions.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Megavog MF 0.3/500 mg Tablet.
- Regular physical activity can enhance the effectiveness of this medication; aim for at least 150 minutes of moderate exercise weekly.
- Avoid excessive consumption of sugary foods and beverages to help manage blood sugar levels effectively.
- Stay hydrated by drinking plenty of water throughout the day while on Megavog MF 0.3/500 mg Tablet.
- Monitor blood glucose levels regularly to assess the effectiveness of the treatment plan.
Side Effects
- Common side effects associated with Megavog MF 0.3/500 mg Tablet include gastrointestinal disturbances such as nausea, vomiting, and diarrhea.
- Some patients may experience abdominal discomfort or bloating while taking this medication.
- Serious side effects can include lactic acidosis, especially in patients with renal impairment.
- Signs of lactic acidosis include unusual muscle pain, difficulty breathing, and feeling cold or dizzy; immediate medical attention is required if these occur.
- Allergic reactions are rare but can happen; symptoms may include rash, itching, or swelling.
- Patients should report any persistent side effects to their healthcare provider for further evaluation.
Precautions and Warnings
- Megavog MF 0.3/500 mg Tablet should not be used by individuals with known hypersensitivity to Metformin or Voglibose.
- This medication is contraindicated in patients with severe renal impairment or acute metabolic acidosis.
- Pregnant or breastfeeding women should consult their healthcare provider before using Megavog MF 0.3/500 mg Tablet.
- Caution is advised when driving or operating machinery until individual responses to the medication are known.
- Alcohol consumption should be limited while taking Megavog MF 0.3/500 mg Tablet due to the risk of lactic acidosis.
- Patients with liver disease should use this medication under strict medical supervision.
- Regular monitoring of kidney function is recommended during treatment with Megavog MF 0.3/500 mg Tablet.
Megavog MF 0.3/500 mg Tablet is primarily used for managing blood sugar levels in individuals with type 2 diabetes.
2. How should I take Megavog MF 0.3/500 mg Tablet?
It is recommended to take Megavog MF 0.3/500 mg Tablet orally with meals as prescribed by your healthcare provider.
3. What are the common side effects?
Common side effects may include gastrointestinal issues such as nausea, vomiting, and diarrhea.
4. Can I drink alcohol while taking this medication?
It is advisable to limit alcohol intake while using Megavog MF 0.3/500 mg Tablet due to potential risks.
5. Who should avoid using Megavog MF 0.3/500 mg Tablet?
Individuals with severe renal impairment or hypersensitivity to its components should avoid using this medication.
6. How does this medication work?
Megavog MF 0.3/500 mg Tablet works by combining Metformin and Voglibose to lower blood sugar levels effectively.
7. What should I do if I miss a dose?
If you miss a dose of Megavog MF 0.3/500 mg Tablet, take it as soon as you remember unless it's almost time for your next dose.
Directions for Use
Storage and Disposal
| SKU | 102063 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Aristo Pharmaceuticals Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account